Búsqueda | Biblioteca Virtual en Salud

Lavelle, John P; Karram, Mickey; Chu, Franklin M; Dmochowski, Roger; MacDiarmid, Scott A; Staskin, David R; Sand, Peter K; Appell, Rodney; Erdem, Nurum.

Am J Med ; 119(3 Suppl 1): 37-40, 2006 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-16483867

16.

Rare cause of ureteral obstruction.

Gaston, Kris E; Gabriel, Don A; Lavelle, John P.

Urology ; 66(5): 1110, 2005 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-16286146

17.

Plasma cell (Zoon's) balanitis with concomitant HIV infection.

Houser, Edward R; Gaston, Kris E; Funkhouser, William K; Israel, Bruce; Lavelle, John P.

Urology ; 66(3): 657, 2005 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16140101

18.

The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy.

Fraser, Matthew O; Lavelle, John P; Sacks, Michael S; Chancellor, Michael B.

Rev Urol ; 4(1): 1-11, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-16985646

19.

Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.

Chuang, Yao-Chi; Chancellor, Michael B; Seki, Satoshi; Yoshimura, Naoki; Tyagi, Pradeep; Huang, Leaf; Lavelle, John P; De Groat, William C; Fraser, Matthew O.

Urology ; 61(3): 664-70, 2003 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-12639680

20.

Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis.

Kanai, Anthony J; Zeidel, Mark L; Lavelle, John P; Greenberger, Joel S; Birder, Lori A; de Groat, William C; Apodaca, Gerard L; Meyers, Susan A; Ramage, Richard; Epperly, Michael W.

Am J Physiol Renal Physiol ; 283(6): F1304-12, 2002 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-12426235

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Editorial Comment.

Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine.

Editorial Comment.

Editorial Comment.

Correlating spinal cord injuries with neurogenic bladder pathophysiology.

Re: Hanna-Mitchell AT, Wolf-Johnston AS, Barrick SR, et al. Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn 2015;34:79-84.

Incontinence related to management of benign prostatic hypertrophy.

The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

Intermittent Catheters: To reuse or not.

EDITORIAL COMMENT.

On when guidelines conflict: Patient safety, quality of life and CAUTI reduction in patients with spinal cord injury.

The economic impact of prostate cancer screening and treatment.

Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.

An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.

Management of incontinence for family practice physicians.

Rare cause of ureteral obstruction.

Plasma cell (Zoon's) balanitis with concomitant HIV infection.

The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy.

Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.

Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis.